In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patients

• Main Authors: San Jiun Chai (Author), Sammuel Chee Yong Fong (Author), Chai Phei Gan (Author), Kin Choo Pua (Author), Paul Vey Hong Lim (Author), Shin Hin Lau (Author), Rosnah Binti Zain (Author), Thomas Abraham (Author), Siti Mazlipah Ismail (Author), Zainal Ariff Abdul Rahman (Author), Sathibalan Ponniah (Author), Vyomesh Patel (Author), Sok Ching Cheong (Author), Kue Peng Lim (Author)
• Format: Book
• Published: Taylor & Francis Group, 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Peptide vaccines derived from tumour-associated antigens have been used as an immunotherapeutic approach to induce specific cytotoxic immune response against tumour. We previously identified that MAGED4B and FJX1 proteins are overexpressed in HNSCC patients; and further demonstrated that two HLA-A2-...